Neil Cashman

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Toronto, Ontario, Canada
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Max A. Milbury, Attorney in Fact for Neil Cashman
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Neil Cashman

Form 4 holding Chief Scientific Officer, Director

ProMIS Neurosciences Inc.

Security class
Option (right to buy)
Shares / value
50,000
Estimated value
Report date
20 May 2026
Price
Ownership
Direct
Underlying class
Common Shares
Underlying amount
Form 4 holding Chief Scientific Officer, Director

ProMIS Neurosciences Inc.

Security class
Warrants to purchase Common Shares
Shares / value
4,122
Estimated value
Report date
03 Feb 2026
Price
Ownership
By Research Capital Corporation
Underlying class
Common Shares
Underlying amount

Insider Reports Filed by Neil Cashman

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .